Skip to main content

Well-Known NJ Addiction Specialist Dr. Constantine Diakolios Joins Sunrise House Treatment Team

Written by Customer Service on . Posted in Public Companies.

LAFAYETTE, N.J., Nov. 16, 2020 (GLOBE NEWSWIRE) — Sunrise House Treatment Center has expanded its medical team to include one of New Jersey’s top addiction specialists. Dr. Constantine Diakolios has detoxed more than 30,000 patients in his 15-year career, and is a 2018 fellow of the American Society of Addiction Medicine, a distinction given to leading members in the field. He is also board certified in addiction medicine and was among the first physicians in the state to offer his patients suboxone, the gold standard of treatment for opioid addiction. He also specializes in high-risk patients and those struggling with pain management in the midst of their addiction.
“I’m passionate about caring for those with addiction,” said Dr. Diakolios. “For me, it’s personal because I’ve watched too many loved ones battle the disease. The COVID-19 pandemic has only made matters worse with overdoses on the rise. Now more than ever, people need to know they have a quality place to turn to for help.”Dr. Diakolios joins Dr. Evangelos Christodoulou as co-medical directors at Sunrise House. The two have a history of working together to achieve the best patient outcomes. Dr. Christodoulou is a board-certified psychiatrist, while Dr. Diakolios has an internal medicine background. CEO Jim Zuravnsky also worked with both physicians for over 10 years and was excited to bring the team back together.“We are honored to have someone of Dr. Diakolios’ expertise on our team,” said Jim Zuravnsky, Sunrise House Treatment Center CEO. “He could’ve worked anywhere, but he chose Sunrise House based on our long-standing reputation for high-quality addiction treatment. His addition to the team means we now have two of the top addiction specialists in the state caring for our patients.”When Dr. Diakolios was the medical director of Summit Oaks Hospital, the facility received several accolades for their high-quality care, including national recognition as a 2019 Horizon Blue Cross Blue Shield of New Jersey Blue Distinction® Center for Substance Use Treatment and Recovery. Prior to his tenure at Summit Oaks, he supervised a start up detox unit – Promesa Inc., located in the South Bronx, New York City – where he also served as the medical director. Dr. Diakolios brings that same commitment to clinical excellence to Sunrise House Treatment Center. Since joining the team this month, Dr. Diakolios has already made some enhancements to the treatment protocols, including updating the rehab policies to provide the most comfortable detox process for patients.“My treatment approach is based on the premise that patients need more education than they do medication,” said Dr. Diakolios. “I want to do more than just help them get off the drugs or alcohol. It’s important for me to give them the tools on how to stay sober for life.”About Sunrise House Treatment Center
Sunrise House Treatment Center is a part of the American Addiction Centers family of treatment centers. We treat patients who are struggling with drug addiction, alcohol addiction and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at SunriseHouse.com or follow us on Twitter.Contact:
Joy Sutton
Director of Corporate Communications
jsutton@contactaac.com
615-587-7728A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/74140120-e4bb-448d-8dc3-22496cff6dc4

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.